Cholic Acid 相關新聞

← 返回新聞總覽


Cholic Acid 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Cholic Acid 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Orphacol is indicated for the treatment of inborn errors in primary bile acid synthesis due to3β-Hydroxy-Δ5-C27-steroid oxidoreductase deficiency or Δ4-3-Oxosteroid-5β-reductase deficiency ininfants,...
  • 證據等級:L5
  • 預測適應症(20 個):
    • cholelithiasis(99.9%)
    • HIV infectious disease(99.8%)
    • obsolete familial combined hyperlipidemia(99.8%)
    • homozygous familial hypercholesterolemia(99.8%)
    • biotin metabolic disease(99.7%)
    • vitamin deficiency disorder(99.7%)
    • hereditary hemochromatosis(99.7%)
    • neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter(99.7%)
    • hemosiderosis(99.7%)
    • disorder of phenylalanine metabolism(99.6%)
    • bone Paget disease(99.6%)
    • inborn error of biotin metabolism(99.6%)
    • feline acquired immunodeficiency syndrome(99.6%)
    • simian immunodeficiency virus infection(99.6%)
    • obsolete rare hereditary hemochromatosis(99.5%)
    • hyperphenylalaninemia due to tetrahydrobiopterin deficiency(99.5%)
    • inborn disorder of pyridoxine metabolism(99.5%)
    • Wilson disease(99.4%)
    • constitutional megaloblastic anemia due to folate metabolism disorder(99.4%)
    • cerebral folate deficiency(99.4%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.